Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -7905.63% is 257% below its 1-year average of -2211.93%, near the low end of its 1-year range (-7905.63%–-1999.14%).
257.41% below its 12-month average of -2211.93%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2021 (2021-03-31): -1999.14%.
EBITDA MARGIN
-7905.63%
EBITDA MARGIN AVG TTM
-2211.93%
EBITDA MARGIN AVG 3Y
-2211.93%
EBITDA MARGIN AVG 5Y
-2211.93%
EBITDA MARGIN AVG 10Y
-6858.05%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-257.41%
CURRENT VS 3Y AVG
-257.41%
CURRENT VS 5Y AVG
-257.41%
CURRENT VS 10Y AVG
-15.28%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Grace Therapeutics, Inc.
Market Cap
$34.58M
EBITDA Margin
-7905.63%
TTM Avg
-2211.93%
3Y Avg
-2211.93%
5Y Avg
-2211.93%
Market Cap
$34.33M
EBITDA Margin
-6.58%
TTM Avg
-1.77%
3Y Avg
-0.14%
5Y Avg
1.64%
Market Cap
$35.15M
EBITDA Margin
-127.12%
TTM Avg
-129.61%
3Y Avg
-125.08%
5Y Avg
-93.97%
Market Cap
$36.63M
EBITDA Margin
-22.75%
TTM Avg
-133.81%
3Y Avg
-3828.74%
5Y Avg
-3288.72%
Market Cap
$33.23M
EBITDA Margin
-3982.39%
TTM Avg
-3087.93%
3Y Avg
-1849.71%
5Y Avg
-2051.20%
Market Cap
$32.71M
EBITDA Margin
-29.82%
TTM Avg
-228.84%
3Y Avg
-176.67%
5Y Avg
-120.12%
Market Cap
$31.93M
EBITDA Margin
-3.61%
TTM Avg
-0.43%
3Y Avg
-7.34%
5Y Avg
-19.38%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $34.58M | -7905.63% | -2211.93% | -2211.93% | -2211.93% |
| Accuray Incorporated (ARAY)vs › | $34.33M | -6.58% | -1.77% | -0.14% | 1.64% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $35.15M | -127.12% | -129.61% | -125.08% | -93.97% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | -22.75% | -133.81% | -3828.74% | -3288.72% |
| DocGo Inc. (DCGO)vs › | $35.92M | -22.81% | -7.79% | -0.80% | -0.97% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.23M | -3982.39% | -3087.93% | -1849.71% | -2051.20% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.71M | -29.82% | -228.84% | -176.67% | -120.12% |
| Rockwell Medical, Inc. (RMTI)vs › | $31.93M | -3.61% | -0.43% | -7.34% | -19.38% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.70M | -136.01% | -1016.71% | -1237.80% | -1237.80% |
Gross Margin
0.0%
EBITDA Margin
-7905.6%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2021-03-31 | -1999.14% |
| 2020-12-31 | -2424.71% |
| 2016-02-29 | -7537.54% |
| 2015-11-30 | -40061.10% |
| 2015-08-31 | -22368.72% |
| 2015-05-31 | -39217.96% |
| 2015-02-28 | -1010.87% |
| 2014-11-30 | -8261.86% |
| 2014-08-31 | -38071.02% |
| 2014-05-31 | -4259.48% |
| 2014-02-28 | -791.64% |
| 2013-11-30 | -9323.48% |
| 2013-08-31 | -1035.53% |
| 2013-05-31 | -28366.61% |
| 2013-02-28 | -5982.38% |
| 2012-11-30 | -344.00% |
| 2012-08-31 | -663.88% |
| 2012-05-31 | -10638.44% |
| 2012-02-29 | -10551.89% |
| 2011-05-31 | -1026.64% |
| 2011-02-28 | -3479.75% |
